Drug Eluting Stent

Drug-eluting stents (DES) have become the cornerstone of percutaneous coronary interventions in patients with coronary artery disease and are largely responsible for the broad application of percutaneous coronary interventions worldwide.

Have we come to the end of the road in the development of DES?

SUPRAFLEX CRUZ

Ultra-thin DES of 4° generation with 60μn strut thickness across all diameters.  

Expert opinion on TALENT Study

Eminent cardiologists speak about SUPRAFLEX

Read More >

For further information fill the form below